Technology | December 19, 2014

Volpara Solutions Launches VolparaDensity 3.0 for 2-D and 3-D Breast Density Assessment

Software suitable for use with digital mammography and digital breast tomosynthesis

Volpara, VolparaDensity, version 3.0, RSNA 2014

Image courtesy of Volpara Solutions

December 19, 2014 – Volpara Solutions announced the launch of the VolparaDensity version 3.0 breast density assessment tool at the 100th annual meeting of the Radiological Society of North America (RSNA), Nov. 30-Dec. 5 in Chicago. Available clinically for use with digital breast tomosynthesis datasets from multiple manufacturers, the system is already in use at Peninsula Diagnostic Imaging in San Mateo, Calif., and Santa Barbara Women’s Imaging in Santa Barbara, Calif. 

VolparaDensity for use with Hologic tomosynthesis systems will be available immediately and the new version for use with GE and Siemens tomosynthesis units will be available in early 2015.

A digital breast tomosynthesis exam, sometimes called a 3-D mammogram, is performed similarly to a traditional mammogram where the technologist compresses the breast and acquires images from different angles. Tomosynthesis is a multi-view mammography technique where each of the individual tomosynthesis projections acquired is a low dose, 2-D projection mammogram.

“We screen patients with dense breasts with 3-D tomosynthesis while women with fatty breasts continue to get conventional 2-D digital mammography because of the lower dose. We are excited to have the option of providing objective, volumetric breast density for all of our patients as the ability to provide consistent and accurate breast density values is critical to proper patient management. Breast density assessment should be the same no matter if the image was acquired using 2-D or 3-D.  It is, after all, the same breast, so it is very reassuring that VolparaDensity has been highly correlated between mammography and tomosynthesis,” said Susan Marks, M.D., director of breast imaging at Peninsula Diagnostic Imaging.

The VolparaDensity software, which has been in clinical use since 2010, was developed to be suitable for use with both digital mammography and digital breast tomosynthesis data from any manufacturer. It uses the same algorithm to process both the acquired tomosynthesis projections and the raw data of a conventional 2-D mammogram,  and also reduces the challenges of visually determining breast density based on a review of tomosynthesis slices and synthetic 2-D images (C-View from Hologic, V-Preview from GE) and enables consistent density assessments based on each patient’s actual breast tissue composition.

“Informing women about their breast density is critical to their ability to make informed decisions about their breast health. By providing reproducible and consistent volumetric density for 3-D tomosynthesis, VolparaDensity helps improve screening for women with dense breasts by enabling radiologists to more systematically determine which patients would benefit from supplemental imaging such as automated breast ultrasound,” said Judy Dean, M.D., senior radiologist, Santa Barbara Women’s Imaging.

VolparaDensity is in use at breast imaging centers worldwide to help radiologists objectively assess density from both digital mammography and tomosynthesis images and to determine which women would benefit from additional screening. Highly correlated to breast magnteic resonance (MR) assessments, VolparaDensity automatically generates an objective measurement of volumetric breast density correlated to the American College of Radiology (ACR) breast density categories.

For more information: www.volparasolutons.com

Related Content

Novel Technique May Significantly Reduce Breast Biopsies
News | Breast Biopsy Systems | January 17, 2019
A novel technique that uses mammography to determine the biological tissue composition of a tumor could help reduce...
Digital Mammography Increases Breast Cancer Detection
News | Mammography | January 16, 2019
The shift from film to digital mammography increased the detection of breast cancer by 14 percent overall in the United...
Artificial Intelligence Used in Clinical Practice to Measure Breast Density
News | Artificial Intelligence | January 15, 2019
An artificial intelligence (AI) algorithm measures breast density at the level of an experienced mammographer,...
Sponsored Content | Videos | Breast Imaging | January 11, 2019
Supplemental screening with ABUS helps personalize breast care for women with dense breasts and offers advanced...
Electronic Brachytherapy Effective in Long-Term Study of 1,000 Early-Stage Breast Cancers
News | Brachytherapy Systems, Women's Healthcare | January 07, 2019
Breast cancer recurrence rates of patients treated with intraoperative radiation therapy (IORT) using the Xoft Axxent...
Breast Cancer Patients Have Less Heart Damage With Heart Drug and Trastuzumab
News | Cardio-oncology | January 03, 2019
Breast cancer patients who take a heart drug at the same time as trastuzumab have less heart damage, according to a...
Opto-Acoustic Imaging Helps Differentiate Breast Cancer Molecular Subtypes
News | Ultrasound Women's Health | December 20, 2018
Seno Medical Instruments Inc. (Seno Medical) reported results of a study demonstrating that morphologic and functional...
Densitas Enters Platform Partnership With Blackford
News | Breast Density | December 19, 2018
Breast imaging analytics company Densitas Inc. announced the signing of a new Alliance Partner Agreement with Blackford...
Axillary Radiotherapy and Lymph Node Surgery Yield Comparable Outcomes for Breast Cancer
News | Radiation Therapy | December 18, 2018
Early-stage breast cancer patients with cancer detected in a sentinel lymph node biopsy had comparable 10-year...
RSNA Study Shows Real-Time Indicator Improves Mammographic Compression
News | Mammography | December 12, 2018
Sigmascreening recently announced that more than 100,000 women have had mammography exams with the Sensitive Sigma...